Hospital
Sanford Health of Northern Minnesota
Sanford Health of Northern Minnesota was paid $47.45M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 58% of everything it billed.
33Billing provider infoSANFORD HEALTH OF NORTHERN MINNESOTA
BEMIDJI, MN 56601
BEMIDJI, MN 56601
33aNPI1801870191assigned 12/01/2005
33bProvider typeRural Acute Care Hospital
28Total paid$47.45M
24GClaims736,067
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 97,096 | $2.31M | |
| 2019 | 102,709 | $6.74M | |
| 2020 | 96,528 | $6.22M | |
| 2021 | 126,875 | $8.20M | |
| 2022 | 114,198 | $8.35M | |
| 2023 | 119,554 | $8.82M | |
| 2024incomplete | 79,107 | $6.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 58% | 311,508 | 280,696 | $27.60M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.6% | 12,044 | 11,133 | $4.57M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 25,194 | 23,528 | $4.39M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.3% | 5,449 | 5,134 | $1.55M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.7% | 14,435 | 14,184 | $1.28M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 5,328 | 4,956 | $720K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.4% | 7,405 | 7,113 | $655K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,738 | 4,483 | $421K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,768 | 1,651 | $392K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,552 | 4,337 | $342K |
| 20611 | <1% | 1,482 | 1,353 | $312K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 4,132 | 4,034 | $281K |
252 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,204 | $259K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,330 | $229K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 3,771 | $214K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,624 | $188K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,634 | $181K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 954 | $180K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 781 | $173K |
| 59025 | Fetal non-stress test | <1% | 1,043 | $153K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,547 | $152K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 122 | $143K |
| D0240 | <1% | 174 | $138K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,626 | $133K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 781 | $107K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,459 | $106K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 721 | $104K |
| 92587 | <1% | 521 | $102K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,493 | $100K |
| D0120 | Dental checkup, returning patient | <1% | 174 | $100K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 315 | $97K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,511 | $94K |
| 36415 | Collection of venous blood by venipuncture | <1% | 67,054 | $83K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,107 | $75K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,322 | $72K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 689 | $65K |
| 92557 | <1% | 980 | $63K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 182 | $62K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 36 | $57K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 430 | $57K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,943 | $55K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 779 | $55K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,557 | $52K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 14,417 | $51K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,868 | $51K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $50K |
| 80053 | Comprehensive metabolic panel | <1% | 30,820 | $45K |
| J0178 | Injection, aflibercept, 1 mg | <1% | 39 | $39K |
| 0240U | <1% | 751 | $38K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,003 | $38K |
| 90686 | <1% | 5,695 | $37K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 147 | $35K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 421 | $33K |
| 92060 | <1% | 836 | $30K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,311 | $29K |
| 86780 | <1% | 2,076 | $27K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 88 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 447 | $26K |
| 80061 | Lipid panel | <1% | 2,994 | $25K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 286 | $23K |
| 93296 | <1% | 920 | $22K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 424 | $21K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 93 | $21K |
| 0002A | <1% | 751 | $20K | |
| 0001A | <1% | 820 | $20K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 719 | $19K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 606 | $18K |
| 92567 | <1% | 2,017 | $17K | |
| J3490 | Unclassified drugs | <1% | 20,062 | $16K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 718 | $16K |
| Q3014 | Telehealth originating site facility fee | <1% | 1,302 | $15K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 599 | $15K |
| 73630 | <1% | 890 | $15K | |
| 51798 | <1% | 802 | $14K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 67 | $14K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $13K |
| 97802 | <1% | 201 | $13K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 177 | $13K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 944 | $12K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 381 | $10K |
| 11102 | <1% | 54 | $10K | |
| 92134 | <1% | 2,696 | $9K | |
| G0378 | Hospital observation service, per hour | <1% | 66 | $9K |
| 0012A | <1% | 320 | $9K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 81 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 299 | $9K |
| D1120 | Dental cleaning, child | <1% | 173 | $8K |
| D1206 | Topical application of fluoride varnish | <1% | 172 | $7K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 15 | $7K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 622 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 377 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,199 | $7K |
| 86850 | <1% | 600 | $6K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 169 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 45 | $6K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,446 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 361 | $6K |
| 76801 | <1% | 65 | $6K | |
| 20610 | <1% | 109 | $6K | |
| 98940 | <1% | 269 | $5K | |
| 90671 | <1% | 24 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $5K |
| 84484 | <1% | 3,189 | $5K | |
| 80306 | <1% | 1,482 | $5K | |
| 85018 | <1% | 2,211 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,322 | $5K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $5K |
| 11900 | <1% | 31 | $5K | |
| 0071A | <1% | 138 | $5K | |
| 29075 | <1% | 19 | $5K | |
| 81025 | <1% | 282 | $5K | |
| 86900 | <1% | 521 | $4K | |
| 91320 | <1% | 127 | $4K | |
| 85027 | <1% | 1,787 | $4K | |
| 0011A | <1% | 327 | $4K | |
| 17110 | <1% | 39 | $4K | |
| 0124A | <1% | 228 | $4K | |
| 97597 | <1% | 44 | $4K | |
| 29065 | <1% | 18 | $4K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 157 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,483 | $4K |
| 0072A | <1% | 101 | $4K | |
| 99381 | <1% | 53 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,536 | $4K |
| 99406 | <1% | 175 | $4K | |
| 80050 | General health panel | <1% | 134 | $3K |
| 90670 | <1% | 387 | $3K | |
| 90480 | <1% | 213 | $3K | |
| 73565 | <1% | 201 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 521 | $3K |
| 81001 | <1% | 6,379 | $3K | |
| 99495 | <1% | 44 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 824 | $3K |
| J2704 | Injection, propofol, 10 mg | <1% | 3,763 | $3K |
| 82077 | <1% | 1,238 | $3K | |
| 90739 | <1% | 25 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 116 | $3K |
| 83605 | <1% | 2,058 | $3K | |
| 96130 | <1% | 16 | $3K | |
| 90651 | <1% | 144 | $2K | |
| 86803 | <1% | 333 | $2K | |
| 93298 | <1% | 87 | $2K | |
| 86901 | <1% | 521 | $2K | |
| 0004A | <1% | 83 | $2K | |
| 90732 | <1% | 27 | $2K | |
| 84145 | <1% | 1,265 | $2K | |
| 86762 | <1% | 230 | $2K | |
| 0054A | <1% | 78 | $2K | |
| 99173 | <1% | 599 | $2K | |
| 97803 | <1% | 43 | $2K | |
| 96161 | <1% | 72 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 175 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $2K |
| 87631 | <1% | 386 | $2K | |
| 87340 | <1% | 267 | $2K | |
| 86140 | <1% | 3,547 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 18 | $1K |
| G0008 | Administration of influenza virus vaccine | <1% | 305 | $1K |
| 73610 | <1% | 51 | $1K | |
| 90656 | <1% | 135 | $1K | |
| 73560 | <1% | 238 | $1K | |
| 83690 | <1% | 2,650 | $1K | |
| 90785 | <1% | 254 | $1K | |
| D2940 | <1% | 25 | $1K | |
| 96415 | <1% | 14 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 55 | $1K |
| 99383 | <1% | 14 | $1K | |
| 87081 | <1% | 201 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,241 | $983.73 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 174 | $845.36 |
| 85610 | <1% | 2,296 | $838.77 | |
| 84439 | <1% | 238 | $835.86 | |
| 0064A | <1% | 42 | $770.83 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,839 | $759.71 |
| 82950 | <1% | 153 | $736.50 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 15 | $700.90 |
| 81003 | <1% | 292 | $670.61 | |
| 73030 | <1% | 45 | $651.41 | |
| 87150 | <1% | 29 | $636.78 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 149 | $567.24 |
| 90474 | <1% | 111 | $524.61 | |
| 95819 | <1% | 12 | $511.91 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $491.05 |
| 82607 | <1% | 138 | $462.08 | |
| 93325 | <1% | 26 | $454.43 | |
| 84702 | <1% | 42 | $403.20 | |
| 82728 | <1% | 100 | $377.39 | |
| 73110 | <1% | 35 | $376.53 | |
| 87210 | <1% | 270 | $369.87 | |
| 83735 | <1% | 1,003 | $354.32 | |
| 73140 | <1% | 39 | $352.32 | |
| 99459 | <1% | 62 | $336.60 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 180 | $317.39 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 52 | $316.40 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 169 | $310.49 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 763 | $305.25 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 413 | $292.56 |
| 83550 | <1% | 131 | $282.90 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 947 | $230.47 |
| 83540 | <1% | 131 | $215.86 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,193 | $209.75 |
| 80076 | <1% | 206 | $175.78 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 120 | $166.39 |
| 86592 | <1% | 141 | $163.52 | |
| 82803 | <1% | 12 | $153.46 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 33 | $130.41 |
| 85652 | <1% | 144 | $121.90 | |
| 96381 | <1% | 12 | $116.84 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 29 | $112.65 |
| 90715 | <1% | 82 | $93.97 | |
| C9257 | Injection, bevacizumab, 0.25 mg | <1% | 15 | $93.17 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 53 | $91.46 |
| 82947 | <1% | 68 | $88.08 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $74.12 |
| 84703 | <1% | 267 | $68.20 | |
| 88300 | <1% | 38 | $68.10 | |
| 92555 | <1% | 15 | $67.50 | |
| 90662 | <1% | 26 | $65.91 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 12 | $62.55 |
| 85730 | <1% | 273 | $59.63 | |
| 73130 | <1% | 21 | $58.54 | |
| 83970 | <1% | 15 | $50.92 | |
| 99188 | <1% | 175 | $41.99 | |
| 91300 | <1% | 1,327 | $40.18 | |
| 91307 | <1% | 356 | $40.18 | |
| 88720 | <1% | 35 | $35.03 | |
| 82570 | <1% | 115 | $31.90 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 88 | $31.25 |
| 82040 | <1% | 67 | $28.54 | |
| 85651 | <1% | 64 | $22.10 | |
| 82785 | <1% | 18 | $20.31 | |
| 84153 | <1% | 14 | $18.37 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 37 | $17.30 |
| 87186 | <1% | 69 | $17.22 | |
| 87077 | <1% | 26 | $16.10 | |
| 84478 | <1% | 12 | $14.62 | |
| 82043 | <1% | 41 | $14.26 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 55 | $12.22 |
| 91305 | <1% | 60 | $10.79 | |
| 84156 | <1% | 56 | $9.06 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $2.28 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 2,956 | $0.00 |
| 90734 | 0% | 67 | $0.00 | |
| 91312 | 0% | 85 | $0.00 | |
| 90685 | 0% | 54 | $0.00 | |
| 90710 | 0% | 57 | $0.00 | |
| 90633 | 0% | 71 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 18 | $0.00 |
| 84100 | 0% | 60 | $0.00 | |
| 85379 | 0% | 38 | $0.00 | |
| 90723 | 0% | 223 | $0.00 | |
| 83880 | 0% | 46 | $0.00 | |
| 90647 | 0% | 249 | $0.00 | |
| 80069 | 0% | 14 | $0.00 | |
| 91301 | 0% | 439 | $0.00 | |
| 87040 | 0% | 18 | $0.00 | |
| 90680 | 0% | 109 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 0% | 35 | $0.00 |
| 91319 | 0% | 12 | $0.00 | |
| 92136 | 0% | 13 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 21 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
| 90381 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| Sanford Medical Center | Sioux Falls, SD | $24.40M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Medical Center | Sioux Falls, SD | $18.03M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Health Network North | Thief River Falls, MN | $3.28M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
| Sanford Medical Center Fargo | Mahnomen, MN | $994K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.